Universitätsklinikum Carl Gustav Carus Dresden
Universitätsklinikum Carl Gustav Carus Dresden is a supra-maximal care public university hospital affiliated with TU Dresden, serving Dresden and East Saxony with comprehensive inpatient, outpatient, and research-led specialty care across oncology, neurology, pediatrics, and surgery.
- Company typePrivate
- Founded1999
- HeadquartersDresden, Germany
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What Universitätsklinikum Carl Gustav Carus Dresden does
Universitätsklinikum Carl Gustav Carus Dresden is a supra-maximal care (Maximalversorgung) public university hospital affiliated with the Medical Faculty Carl Gustav Carus of the Technische Universität Dresden. It is a public-law institution (Anstalt des öffentlichen Rechts) of the Free State of Saxony, headquartered at Fetscherstraße 74 in Dresden, operating with 5,001-10,000 staff and serving as the primary regional referral center for complex, serious, and rare diseases across Dresden and East Saxony. The hospital runs 24/7 emergency services, dedicated university centers across oncology, neurology, pediatrics, gynecology, surgery, and specialized chronic disease care, and is the anchor partner of the Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC) jointly operated with DKFZ.
The hospital's clinical and research technology stack includes two da Vinci robotic surgery systems (over 4,100 urological procedures performed across 20 years), a proton therapy facility (Universitäts Protonen Therapie Dresden), CAR-T cell therapy including the world's first successful treatment for primary immune thrombocytopenia, whole genome sequencing under Section 64e SGB V, AI-assisted stroke routing via the DETECT telemedical network, the CIRCULATE circulating tumor DNA blood test for colorectal cancer, and molecular tumor board infrastructure consolidated through the ZPMO Dresden center. It supports a workforce training pipeline of 17 different apprenticeships via the Carus Akademie and interprofessional simulation through the ISIMED Simulation Center.
Universitätsklinikum Dresden's revenue is generated primarily through statutory (GKV) and private (PKV) health insurance reimbursements for inpatient and outpatient services priced under the German DRG system and GOÄ, supplemented by research grants (including an EUR 41 million Federal Ministry of Health award for PEDNET-LC and Deutsche Krebshilfe funding), donations channeled through Stiftung Hochschulmedizin Dresden (over EUR 1 million allocated in 2025), and consulting/medical advisory services from its subsidiary Carus Consilium Sachsen GmbH. GTM is essentially regional referral-based: it accepts patients from general practitioners and regional hospitals across Saxony and extends specialist reach via telemedicine networks (17 partner clinics for intensive care and stroke) and regional Medizinische Versorgungszentren, with no third-party payer-side commercial sales motion.
Universitätsklinikum Carl Gustav Carus Dresden firmographics
Firmographics- Name
- Universitätsklinikum Carl Gustav Carus Dresden
- Legal name
- Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
- Website
- https://uniklinikum-dresden.de
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Universitätsklinikum Carl Gustav Carus Dresden is a supra-maximal care public university hospital affiliated with TU Dresden, serving Dresden and East Saxony with comprehensive inpatient, outpatient, and research-led specialty care across oncology, neurology, pediatrics, and surgery.
- Ownership category
- akta.pro rank
Universitätsklinikum Carl Gustav Carus Dresden industry classification
Industry- Product category
- University Hospital Healthcare Services
- NAICS
- General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)
- akta.pro primary industry
- Community & Regional General Hospitals (HLAFAAAB)
- akta.pro secondary industries
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Specialty Palliative Care (e.g., oncology, CHF/COPD, dementia) (HLADAHAJ)
Keywords
Where Universitätsklinikum Carl Gustav Carus Dresden is headquartered
LocationHeadquarters
- HQ city
- Dresden
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Universitätsklinikum Carl Gustav Carus Dresden business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Healthcare Services Revenue: As a public university hospital in Germany, the primary revenue comes from reimbursements for medical services provided to patients covered by statutory health insurance (GKV) and private health insurance (PKV). Services include inpatient care, outpatient treatments, and specialized medical procedures.
- Research Grants and Project Funding: Significant funding from government sources including Federal Ministry for Research (BMFT), German Cancer Aid (Deutsche Krebshilfe), and European research programs for clinical trials and translational research projects.
- Donations and Charitable Support: Stiftung Hochschulmedizin Dresden foundation collects donations supporting patient care, research, and education projects beyond regular funding. In 2025, over 1 million euros were allocated for teaching, research, and patient care.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Standard hospital services covered by statutory health insurance |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Universitätsklinikum Carl Gustav Carus Dresden product offering
Product offeringCore offering
Universitätsklinikum Carl Gustav Carus Dresden is a supra-maximal care university hospital providing comprehensive inpatient and outpatient medical, surgical, and specialist care across all disciplines. Core offerings include advanced oncology treatment (proton therapy, CAR-T cell therapy, stem cell transplantation), robotic surgery, genomic and molecular diagnostics, intensive care, pediatric palliative care, plus integrated medical research and university-level education/training programs. The hospital serves as the primary regional referral center for complex, serious, and rare diseases in Dresden and East Saxony.
Product overview
Universitätsklinikum Carl Gustav Carus Dresden is a supra-maximal care university hospital offering a comprehensive portfolio of clinical services, specialized centers, and educational programs. The hospital operates as a single institutional entity with numerous specialized care centers (UniversitätsCentren) including oncology (NCT/UCC, ZPMO Dresden), pediatric care (Kinder-Frauenzentrum, Sächsisches Kinderpalliativzentrum), neurology (Neuroonkologisches Zentrum, ParkinsonCentrum, DemenzCentrum), and surgical specialties. Supporting infrastructure includes the ISIMED Simulation Center for medical training, the Carus Akademie for professional education, and the Stiftung Hochschulmedizin foundation for fundraising. Patient-facing digital services include a multilingual website with clinical information and a dedicated careers portal. The institution's website (uniklinikum-dresden.de) serves as the primary digital platform for institutional communication.
Differentiator
Problem solved
Functional benefit
Products and services
- Sächsisches Kinderpalliativzentrum (Saxon Pediatric Palliative Care Center) Specialized pediatric palliative care center coordinating palliative services across Saxony, providing support for children with life-limiting conditions and their families through stationary and ambulatory care.
- ZPMO Dresden - Zentrum für Personalisierte Medizin in der Onkologie Center for Personalized Medicine in Oncology offering comprehensive tumor characterization programs including whole genome sequencing for advanced cancer patients through molecular tumor boards.
- NCT/UCC Dresden - Nationales Centrum für Tumorerkrankungen National Cancer Treatment Center combining comprehensive clinical and scientific services for cancer care with the German Cancer Research Center (DKFZ).
- Universitäts Protonen Therapie Dresden Proton therapy services for cancer treatment as part of the Strahlentherapie und Radioonkologie department, providing precision radiation therapy for cancer patients.
- ISIMED Simulation Center Simulation training center offering courses in emergency medicine, crisis management, and clinical skills using state-of-the-art patient simulators, including Advanced Life Support, Pediatric Life Support, and Crisis Resource Management courses.
- Carus Akademie Professional academy offering general and customized training and continuing education courses for all hospital departments and external healthcare professionals.
- Universitäts Krebszentrum (UCC) - Interdisciplinary Oncology Care University cancer center providing interdisciplinary oncology care including the Mildred-Scheel Stem Cell Transplantation Center, gynecological cancer center, skin tumor center, head-neck tumor center, sarcoma center, uro-oncological center, and visceral oncological center.
- Comprehensive Spine Center (UCSC) Comprehensive spine center providing multidisciplinary care for complex spinal conditions.
- Neuroonkologisches Zentrum (Neuro-Oncology Center) Neuro-oncology center providing specialized treatment for brain and nervous system tumors.
- DemenzCentrum Dementia center providing specialized care and research for patients with dementia conditions.
- Interdisziplinäres Zentrum für Intensivmedizin (Interdisciplinary Intensive Care Center) Interdisciplinary intensive care medicine center coordinating intensive care services across 17 partner clinics in East Saxony.
- Kopf-Hals-Tumorzentrum (Head and Neck Tumor Center) Head and neck tumor center providing interdisciplinary cancer care for tumors in the head and neck region.
- MukoviszidoseCentrum (Cystic Fibrosis Center) Cystic fibrosis center providing specialized care for patients with cystic fibrosis.
- NeuroMuskuläresCentrum Neuromuscular center providing specialized care for patients with neuromuscular conditions.
- ParkinsonCentrum Parkinson's center providing specialized care and treatment for patients with Parkinson's disease.
- UniversitätsKontinenz- und BeckenbodenCentrum Continence and pelvic floor center combining urology, gynecology, visceral/thoracic/vascular surgery, physiotherapy, and continence/urotherapy services.
- Universitäts-Physiotherapie-Zentrum (Physiotherapy Center) Physiotherapy center providing rehabilitation services to hospital patients, collaborating with physicians, nursing staff, social services, and other therapeutic disciplines.
- Telemedical Stroke Network East Saxony (DETECT) Telemedical stroke network connecting 17 partner clinics in East Saxony for stroke care, providing remote diagnostics and treatment guidance to regional hospitals.
- Robot-assisted Urological Surgery Program Robotic surgery using da Vinci systems for urological procedures, with over 4,100 operations performed by the program; thoracic surgery also utilizes robotic and minimally invasive techniques.
- Telemedicine MS Care (Expertenwissen für Menschen mit MS im ländlichen Raum) Pilot project providing specialized telemedical Multiple Sclerosis care to patients in rural and medically underserved regions of Saxony.
- Medical Apprenticeships (17 vocational training programs) 17 different apprenticeship programs covering nursing, medical-technical, and therapeutic professions, making the hospital one of the largest vocational training providers in Saxony.
Quantifiable outcome
- Ranked among top 10 transplant centers in Europe
- +5 more outcomes
Companies that use Universitätsklinikum Carl Gustav Carus Dresden
Customer profileNamed customers5 records
Segments1 record
Ideal customer profiles2 records
Universitätsklinikum Carl Gustav Carus Dresden technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Universitätsklinikum Carl Gustav Carus Dresden partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core and minor.
- NCT/UCC Dresden (Nationales Centrum für Tumorerkrankungen)coreComprehensive cancer center jointly operated with German Cancer Research Center (DKFZ). Combines clinical care, research, and translation of scientific findings into patient treatments. Home to ZPMO Dresden and multiple specialized oncology programs.
- Helmholtz-Zentrum Dresden-Rossendorf (HZDR)coreResearch collaboration in oncology and medical technologies, particularly in proton therapy and molecular diagnostics.
- German Cancer Research Center (DKFZ)coreCollaboration through NCT/UCC Dresden and participation in DKTK (German Cancer Consortium Translational Oncology) MASTER-Program for whole genome sequencing.
- German Network for Personalized Medicine (DNPM)coreZPMO Dresden participates in this nationwide network for personalized medicine, enabling national connectivity of expertise.
- Deutsche Krebshilfe (German Cancer Aid)coreFunding partner for research projects including melanoma follow-up care program (888,500 EUR) involving Dresden, Magdeburg, and Regensburg.
- Sonnenstrahl e.V. DresdencoreCharitable organization co-located in Haus Sonnenstrahl with Sächsisches Kinderpalliativzentrum. Long-standing partnership since 2001 for pediatric palliative care.
- Stiftung Hochschulmedizin DresdencoreFoundation supporting university medicine through donations for research, teaching, and patient care. Allocated over 1 million EUR in 2025 for various projects.
- University Hospital MagdeburgcoreCollaborative development of CAR-T cell therapy for autoimmune diseases, including world's first successful treatment for primary ITP published in The Lancet.
- European Society for Blood and Marrow Transplantation (EBMT)coreParticipation in EBMT quality comparisons and certification programs. Ranked among top 10 European transplant centers.
- ElblandklinikencoreRegional hospital network partner in Demenz-Netzwerk for early detection and interdisciplinary collaboration in East Saxony.
- 17 Partner Clinics (Interdisciplinary Center for Intensive Medicine)coreRegional hospital network connecting 17 partner hospitals in East Saxony for coordinated intensive care patient transfers and treatment.
- Städtisches Klinikum DresdenminorExternal cooperation partner of ZPMO Dresden for molecular tumor diagnostics and personalized oncology.
- Diakonissenkrankenhaus DresdenminorExternal cooperation partner of ZPMO Dresden for molecular tumor diagnostics.
- Helios Klinikum Bad SaarowminorExternal cooperation partner of ZPMO Dresden for molecular tumor diagnostics.
- AvenCell TherapeuticsminorBiotech company for which Dr. Martin Wermke serves as clinical presenter for Phase 1 CAR-T therapy results at EHA 2026.
- Carus Consilium Sachsen GmbHminorConsulting subsidiary of the university hospital providing expert medical consultation services to other healthcare providers.
Scale indicators11 records
Recent moves9 records
Expansion highlights6 records
Universitätsklinikum Carl Gustav Carus Dresden competitors and assessment
Company assessmentDirect peers
- Universitätsklinikum Leipzig: Saxony's other university hospital, providing supra-maximal care with overlapping specialty coverage including oncology and transplantation. Most direct regional competitor for patient referrals in Saxony and East Germany, and likely partner in some statewide initiatives.
- Universitätsklinikum Freiburg: Comprehensive university hospital in Baden-Württemberg providing supra-maximal care, with comparable specialty center structure, comprehensive cancer program, and academic-medical integration. Direct competitor for German Cancer Aid and DKTK research funding.
- Universitätsklinikum Heidelberg: Major German university hospital with comparable supra-maximal care designation, National Center for Tumor Diseases (NCT) partnership with DKFZ, and strong specialty oncology and transplant programs. Directly competes with Dresden for federal research funding, top clinician talent, and complex oncology referrals.
- LMU Klinikum München: Bavarian university hospital of comparable scale and supra-maximal care status, with extensive specialty centers, comprehensive cancer programs, and similar academic-medical integration. Competes for talent, federal grants, and complex referrals in the southern German market.
- Charité – Universitätsmedizin Berlin: Germany's largest university hospital and most research-intensive supra-maximal care institution. Directly comparable as a public university hospital providing maximum care across all specialties, with similar integration of research, teaching, and complex clinical services, though at meaningfully larger scale and broader geographic reach.
- Universitätsklinikum Erlangen: Bavarian university hospital with similar supra-maximal care designation, comprehensive cancer center, and translational research programs through its partnership with Friedrich-Alexander-Universität. Comparable in scale and research intensity, competing for the same federal Innovation Fund grants.
- Universitätsklinikum Tübingen: Baden-Württemberg university hospital with strong neurology, oncology, and rare disease programs. Comparable as a public university hospital competing for top research talent, federal grants, and complex case referrals in southwestern Germany.
- Universitätsklinikum Hamburg-Eppendorf (UKE): Hamburg's university hospital with comparable supra-maximal care role in northern Germany, strong oncology and transplant programs, and similar public-law institutional structure. Direct competitor for federal research funding and complex patient referrals in the North German region.
Broad incumbents
- Asklepios Kliniken: Major private German hospital group with broad portfolio including academic and specialty facilities. Competes as a broad incumbent for inpatient volumes, outpatient services, and partnerships with statutory health insurance funds across multiple German regions.
- Helios Kliniken (Fresenius): Germany's largest private hospital operator with extensive geographic footprint across the country. Acts as a broad incumbent providing both general and specialty care, competing for routine referrals and some complex cases in regions adjacent to Dresden.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Universitätsklinikum Carl Gustav Carus Dresden social profiles
Digital presenceUniversitätsklinikum Carl Gustav Carus Dresden financial estimates
Financial estimateRevenue estimate
Valuation estimate
Universitätsklinikum Carl Gustav Carus Dresden leadership team
Management profileNumber of profiles
Profiles13 records
Universitätsklinikum Carl Gustav Carus Dresden subsidiaries and ownership
Company hierarchySubsidiaries1 record
Universitätsklinikum Carl Gustav Carus Dresden funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Universitätsklinikum Carl Gustav Carus Dresden M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Universitätsklinikum Carl Gustav Carus Dresden
What does Universitätsklinikum Carl Gustav Carus Dresden do?
Universitätsklinikum Carl Gustav Carus Dresden is a supra-maximal care university hospital providing comprehensive inpatient and outpatient medical, surgical, and specialist care across all disciplines. Core offerings include advanced oncology treatment (proton therapy, CAR-T cell therapy, stem cell transplantation), robotic surgery, genomic and molecular diagnostics, intensive care, pediatric palliative care, plus integrated medical research and university-level education/training programs. The hospital serves as the primary regional referral center for complex, serious, and rare diseases in Dresden and East Saxony.
Is Universitätsklinikum Carl Gustav Carus Dresden a public or private company?
Universitätsklinikum Carl Gustav Carus Dresden is a private company. It is classified as state government owned and is currently operating.
When was Universitätsklinikum Carl Gustav Carus Dresden founded?
Universitätsklinikum Carl Gustav Carus Dresden was founded in 1999. It employs 5,001 to 10,000 people.
Where is Universitätsklinikum Carl Gustav Carus Dresden based?
Universitätsklinikum Carl Gustav Carus Dresden is headquartered in Dresden, Germany, in the Europe region.
How does Universitätsklinikum Carl Gustav Carus Dresden make money?
Three revenue lines are on record. Healthcare Services Revenue is the primary driver. The others are research Grants and Project Funding and donations and Charitable Support.
Who are Universitätsklinikum Carl Gustav Carus Dresden's main competitors?
Direct peers on record are Universitätsklinikum Leipzig, Universitätsklinikum Freiburg, Universitätsklinikum Heidelberg, LMU Klinikum München, Charité – Universitätsmedizin Berlin, Universitätsklinikum Erlangen, Universitätsklinikum Tübingen and Universitätsklinikum Hamburg-Eppendorf (UKE). Broad incumbents are Asklepios Kliniken and Helios Kliniken (Fresenius).
Does Universitätsklinikum Carl Gustav Carus Dresden have an API?
No public API is recorded for Universitätsklinikum Carl Gustav Carus Dresden.
What industry is Universitätsklinikum Carl Gustav Carus Dresden in?
Universitätsklinikum Carl Gustav Carus Dresden's product category is University Hospital Healthcare Services. Its primary akta.pro industry code is HLAFAAAB, Community & Regional General Hospitals, with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 62211 and its SIC code is 8062.